Sleep Aids Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The sleep aids market is segmented by Product (Mattresses and Pillows, Sleep Laboratory Services, Medication, and Others), Sleep Disorder (Insomnia, Sleep Apnea, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

sleeping aids market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The sleep aids market is expected to grow at a CAGR of 6.5% over the forecast period, 2022-2027.

The COVID-19 pandemic impacted the studied market significantly. The initial phase of the pandemic resulted in unprecedented health concerns and adversely affected communities, industries, businesses, and lives around the world and is continuing to affect individuals' health aspects owing to the emergence of new variants of the SARS-CoV-2 virus. COVID-19 had a profound impact on people having sleep disorders, as sleep loss and feelings of daytime exhaustion were caused by stress and anxiety brought on by the pandemic. Longer shifts that require workers to change their sleep cycles presented another issue for certain frontline workers and medical personnel. In addition, social exclusion, remote education, and limitations on daily activities caused depression among patients, which increased their risk of sleep problems such as insomnia. As per the article titled "Sleep Guidelines During the COVID-19 Pandemic" published by the Sleep Foundation Organization in March 2022, COVID-19 has altered and interrupted sleep patterns in a variety of ways, according to medical professionals and sleep scientists over the last two years. The article further stated that studies have found that the prevalence of insomnia symptoms among adults, children, and adolescents had increased noticeably, and almost 40% of people report having trouble sleeping. This increase in sleep disorders is expected to have a positive impact on the sleep aids market throughout the pandemic phase.

Furthermore, factors such as the growing prevalence of insomnia and other disorders and the increasing adoption of wearable monitors and sensors are expected to increase the market's growth. According to an article published in December 2021 titled "Association between the course of hypnotics treatment for insomnia and work functioning impairment in Japanese workers," sleep disorders that last a month or longer are common among Japanese people, accounting for about 20% of the population. In Japan, the economic cost of sleep problems, such as insomnia, is estimated to be around JPY 3,500 billion (about USD 3 billion). Moreover, according to the study titled "Management of insomnia in primary care" published in August 2021, chronic insomnia is the most common sleep problem in Australia, affecting 12.2% of adults. The associated healthcare expenditures are USD 1.24 billion, with a lost productivity cost of USD 12.19 billion. Thus, the rising prevalence of insomnia, as well as spending on the treatment of insomnia across the countries, is predicted to fuel the market's growth over the forecast period.

Additionally, wearable technologies are advancing market growth by providing better technological support. For instance, the article published by the American Association of Sleep Technologists (AAST) in February 2022 stated that the advantages of wearable sleep technology include the ability to record data over a prolonged length of time and the ability to gather data about a person's sleep in their natural environment. As a result, end consumers are increasingly using wearable sleep technology or devices to measure components of sleep such as sleep/wake cycles.

Hence, due to the abovementioned factors, the market is likely to grow in the future. However, the side effects associated with sleep medications are likely to hinder the market's growth.

Scope of the Report

As per the scope, sleep aid is a treatment that uses devices or supplemental or herbal compounds to help induce the onset of sleep and to ensure that a patient stays asleep. Sleep aids are most popular among people who have chronic sleep disturbances, particularly insomnia. The sleep aids market is segmented by Product (Mattresses and Pillows, Sleep Laboratory Services, Medication, and Others), Sleep Disorder (Insomnia, Sleep Apnea, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Mattresses and Pillows
Sleep Laboratory Services
By Sleep Disorder
Sleep Apnea
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Insomnia Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Insomnia is known as a common sleep disorder that can make it hard to fall asleep, hard to stay asleep or cause to wake up too early and have difficulty getting back to sleep. The increasing prevalence of insomnia among the target population, the implementation of strategic initiatives by the market players, and the growing focus on the research and development of sleeping aid systems for sleep disorders are some of the major factors that are expected to contribute to the segment's growth.

In the article titled "International study of the prevalence and factors associated with insomnia in the general population" published in June 2021, a comparison of the prevalence of insomnia in 57,298 participants across 13 countries using the same methodology was shown. As per the study results, out of the 57,298 participants, 11.3% had a diagnosis of short-term insomnia disorder, with significant differences in prevalence between sites, ranging from 2.3% to 25.5%. Thus, such an increase in the patient population suffering from insomnia is expected to boost the demand for sleeping aids, in turn driving the segment’s growth.

Additionally, the growing focus on research and development activities for sleeping aid systems is increasing the adoption of devices among insomnia patients, thereby contributing to the segment’s growth. For instance, as per a July 2021 update, a research project led by National Cheng Kung University (NCKU) Professor Sheng-Fu Liang developed an intelligent neurofeedback training and sleep quality assessment system for chronic insomnia, especially for residual insomnia, the treatment of which is largely unmet in the management of patients with depression or anxiety. This ongoing project is under the Artificial Intelligence Biomedical Research Center (AIBMRC) and is supported by the Ministry of Science and Technology (MOST) Taiwan to develop innovative artificial intelligence (AI) biomedical technology for smart medicine and smart healthcare.

Moreover, some of the market players are undertaking strategic initiatives such as product launches and development that are projected to aid the segment’s growth. For instance, in October 2021, Interaxon, a consumer neurotechnology and meditation company, launched the second generation of its popular EEG meditation and sleep headband, Muse S. This updated plush brain-sensing headband uses real-time biofeedback.

Thus, the aforementioned factors are likely to drive the growth of the segment during the forecast period.

Sleep Aids Market trend 1

North America is Expected to Dominate the Market Over the Forecast Period

The North America region is expected to dominate the market during the projected period. The market is predicted to be driven by the rising prevalence of insomnia due to several underlying conditions such as depression and anxiety, technical advancements, and research-increasing product launches with the profound impact of COVID-19 lockdowns on Americans in the region. For instance, according to the Survey on COVID-19 and Mental Health (SCMH) in May 2021, 1 in 4 (25%) Canadians of age 18 and older screened positive for symptoms of depression, anxiety, or posttraumatic stress disorder (PTSD).

Furthermore, as per the data published by the National Sleep Foundation in May 2021, in the United States, 35% of all adults reported sleeping less than seven hours every night on average. According to the 2020 Sleep in America Poll by the National Sleep Foundation, more than one-third of individuals don't receive the recommended amount of sleep. Additionally, stress can cause adjustment insomnia, which hampers the functioning of the brain. The Sleep Statistics, updated by the Sleep Foundation in May 2022, stated that with a rate of 49.8% of adults in Camden (New Jersey) and Detroit (Michigan) reported short sleep, and the two cities have the highest rate of sleep disorders. Thus, such an increase in the patient population is expected to increase the adoption rate of sleep aids, thereby driving the market growth in the region.

Moreover, drug approval is another factor augmenting the growth of the market. For instance, in July 2021, the Food and Drug Administration (FDA) approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness (Human African trypanosomiasis) in patients 6 years of age and older and weighing at least 20 kg. Thus, factors such as product launches and drug approvals are among the factors that contribute to the overall growth of the studied market in the region.

Therefore, owing to the abovementioned factors, the market is expected to grow in the North American region over the analysis period.

sleeping aids market growth

Competitive Landscape

Most of the players are based in developing countries due to technological advancements. But due to the ease of connectivity in modern times, these players have also penetrated developing countries and are trying to establish a market in these countries as well. The market is partially fragmented and consists of several major players. Some of the companies which are currently dominating the market are Cadwell, Compumedics Limited, DeVilbiss Healthcare LLC, Merck & Co., Inc., and Natus Medical Incorporated, among others.

Recent Development

In May 2022, Sleepio, an app developed by London-based Big Health Ltd. that uses an algorithm to provide personalized cognitive behavioral therapy (CBT), was launched.

In February 2022, eXciteOSA was launched by Signifier Medical Technologies for snoring and sleep apnea treatment. It is approved for the treatment of primary snoring and mild obstructive sleep apnea (OSA) in adults 18 years or older by the Food and Drug Administration (FDA).

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Insomnia and Other Disorders

      2. 4.2.2 Increasing Adoption of Wearable Monitors and Sensors

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated With Sleep Medications

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Product

      1. 5.1.1 Mattresses and Pillows

      2. 5.1.2 Sleep Laboratory Services

      3. 5.1.3 Medication

      4. 5.1.4 Others

    2. 5.2 By Sleep Disorder

      1. 5.2.1 Insomnia

      2. 5.2.2 Sleep Apnea

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 BMC Medical Co., Ltd

      2. 6.1.2 Cadwell

      3. 6.1.3 Compumedics Limited

      4. 6.1.4 DeVilbiss Healthcare LLC

      5. 6.1.5 Eisai Inc

      6. 6.1.6 Fisher & Paykel Healthcare Limited

      7. 6.1.7 Koninklijke Philips N.V.

      8. 6.1.8 Lowenstein Medical Technology GmbH

      9. 6.1.9 Merck & Co., Inc

      10. 6.1.10 Natus Medical Incorporated

      11. 6.1.11 SleepMed

      12. 6.1.12 Takeda Pharmaceutical Company Limited

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Sleep Aids Market market is studied from 2019 - 2027.

The Global Sleep Aids Market is growing at a CAGR of 6.5% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Cadwell, Compumedics Limited, DeVilbiss Healthcare LLC, Merck & Co., Inc, Natus Medical Incorporated are the major companies operating in Global Sleep Aids Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!